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Abstract
Background: RNA interference (RNAi) is an important anti-viral defense mechanism. The Aedes
aegypti genome encodes RNAi component orthologs, however, most populations of this mosquito
are readily infected by, and subsequently transmit flaviviruses and alphaviruses. The goal of this
study was to use Ae. aegypti as a model system to determine how the mosquito's anti-viral RNAi
pathway interacts with recombinant Sindbis virus (SINV; family Togaviridae, genus Alphavirus).
Results: SINV (TR339-eGFP) (+) strand RNA, infectious virus titers and infection rates transiently
increased in mosquitoes following dsRNA injection to cognate Ago2,  Dcr2, or TSN  mRNAs.
Detection of SINV RNA-derived small RNAs at 2 and 7 days post-infection in non-silenced
mosquitoes provided important confirmation of RNAi pathway activity. Two different recombinant
SINV viruses (MRE16-eGFP and TR339-eGFP) with significant differences in infection kinetics were
used to delineate vector/virus interactions in the midgut. We show virus-dependent effects on
RNAi component transcript and protein levels during infection. Monitoring midgut Ago2, Dcr2, and
TSN transcript levels during infection revealed that only TSN transcripts were significantly increased
in midguts over blood-fed controls. Ago2 protein levels were depleted immediately following a
non-infectious bloodmeal and varied during SINV infection in a virus-dependent manner.
Conclusion: We show that silencing RNAi components in Ae. aegypti results in transient increases
in SINV replication. Furthermore, Ae. aegypti RNAi is active during SINV infection as indicated by
production of virus-specific siRNAs. Lastly, the RNAi response varies in a virus-dependent manner.
These data define important features of RNAi anti-viral defense in Ae. aegypti.
Background
Aedes aegypti is an important vector of arbovirus patho-
gens [1,2]. Understanding anti-viral defense mechanisms
in mosquitoes will help define important features of vec-
tor competence and could lead to novel arbovirus control
strategies. In contrast to what is known about mosquito
responses to bacterial and fungal infections, little has
been published concerning mosquito anti-viral defense
(reviewed in [3]). In addition, there are fundamental dif-
ferences between components of the canonical anti-viral
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defense mechanisms in vertebrates and invertebrates. For
example, orthologous genes for the anti-viral effector mol-
ecules of vertebrates, such as type I interferons, protein
kinase R, and 2'-5' oligoadenylate synthase, are not
present in invertebrate genomes [3,4].
Signal transduction pathways known to be involved in
bacterial and fungal innate immunity can be affected dur-
ing arbovirus infections in vector mosquitoes and other
insects (reviewed in [3]). For example, elements of the
Toll signal transduction pathway are enriched in Ae.
aegypti orally challenged with Sindbis virus (SINV, family,
Togaviridae; genus Alphavirus) [5]. The Janus-kinase signal
transducers and activators of transcription (Jak/STAT) and
Toll signal transduction pathways also are activated in
Drosophila melanogaster during infection with the insect
pathogens Drosophila C virus (DCV; family, Dicistroviri-
dae) and Drosophila X virus (DXV; family Birnaviridae)
[6,7]. However, some key differences are evident between
mosquitoes and the model organism D. melanogaster. For
example, STAT activity is suppressed in Aedes cell culture
during Flavivirus infection (an arbovirus) [8], but stimu-
lated in Drosophila during DCV infection [6,8].
RNA interference (RNAi), an RNA silencing mechanism, is
triggered by the recognition of intracellular long double-
stranded RNAs (dsRNA) and is an important anti-viral
response in invertebrates [9-12]. Because such evidence is
lacking in mosquitoes, we relied on RNAi pathway func-
tional information from model organisms, such as Dro-
sophila. Researchers have long hypothesized that RNA
silencing plays a role in anti-viral defense because of the
presence of dsRNA structures formed by some RNA
viruses in host cells [13]. Recent studies in mutant Dro-
sophila adults confirmed the identity of specific genes that
recognize, recruit and destroy viral RNAs [9-11,14]. Dicer-
2 (Dcr2) is essential for initiation of anti-viral defense in
Drosophila, as it processes long dsRNAs into small interfer-
ing RNAs (siRNAs) of about 21–23 bp [14,15]. Dcr2, with
R2D2, loads one unwound strand of each siRNA into the
multi-component RNA-induced Silencing Complex
(RISC). In the effector phase, a RISC-loaded siRNA strand
is used as a guide for target recognition and cleavage by
Argonaute 2 (Ago2) [16]. In addition to Ago2 and other
proteins, Tudor staphylococcal nuclease (TSN) is also a
component of RISC [17]. This protein has multiple func-
tions, including transcriptional co-activation, non-spe-
cific single-stranded RNA cleavage, and cleavage of hyper-
edited dsRNA substrates [17,18]. Although it plays a clear
role in RNAi, a link to anti-viral defense has not yet been
shown. The Ae. aegypti genome has orthologs to all of
these components [19,20].
Beginning in the mid-1990's, we provided evidence in
both mosquito cell culture and adult mosquitoes that
long dsRNA triggers RNA silencing, which suppresses rep-
lication of arboviruses [21-28]. More recently, we have
shown that in An gambiae, Ago2 and Ago3 are required for
defense against intrathoracically injected O'nyong-nyong
virus (family, Togaviridae; genus Alphavirus) [29]. In addi-
tion, in a transgenic Ae. aegypti line, Ago2 is required for
RNAi-mediated defense against Dengue virus (family Fla-
viviridae; genus Flavivirus) infection [19]. Arbovirus infec-
tion of vector mosquitoes is most influenced by midgut
infection and escape barriers, and to a lesser extent, sali-
vary gland infection barriers, which combine to influence
the ability of a mosquito to serve as a competent vector
(vector competence) [30-32]. A fuller understanding of
the role of RNAi-mediated defense is needed, especially in
light of the knowledge that Ae. aegypti, even with the anti-
viral RNAi arsenal, is often unable to clear a virus infec-
tion before the virus disseminates to the salivary glands
for transmission to a new host.
To determine whether RNAi components are required for
Ae. aegypti anti-viral defense, recombinant Sindbis viruses
(SINV) bearing enhanced green fluorescent protein
(eGFP) markers were used. SINV is not naturally transmit-
ted by Ae. aegypti, therefore, this comprised a model sys-
tem with which to investigate the inherent features of
anti-viral defense. Dcr2, Ago2 and TSN transcripts were
silenced prior to oral infection by the recombinant SINV,
TR339-eGFP. TR339, representing a Paleoarctic/Ethiopian
SINV genotype, when fed at high titer, initiates modest Ae.
aegypti midgut infections that are often cleared by 7 days,
with consequent dissemination rates to distal tissues of
about 40% [33,34]. Here, we show that silencing these
RNAi components results in a transient increase in TR339-
eGFP titers and infection rates, thus supporting roles for
each of these genes in anti-viral defense. Importantly, we
provide evidence of virus genome-derived small RNAs in
un-manipulated SINV-infected mosquitoes, thus confirm-
ing RNAi activity.
In addition, we compared alterations in midgut RNAi
component transcript and protein profiles during infec-
tion with two recombinant SINV strains that exhibit
marked differences in growth kinetics in the mosquito. In
contrast to TR339-eGFP, MRE16-eGFP, representing an
Oriental/Australian SINV genotype, fed at high titer, effi-
ciently and persistently infects Ae. aegypti midguts and dis-
seminates to other tissues in about 80% of mosquitoes
[35]. We found that both RNAi component transcript and
protein levels varied in a virus-dependent manner, high-
lighting the need to consider various virus genotypes in
understanding RNAi-virus interactions.BMC Microbiology 2008, 8:47 http://www.biomedcentral.com/1471-2180/8/47
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Results and Discussion
RNAi components in Ae aegypti
Ae. aegypti Ago2, Dcr2, and TSN genes were identified by
homology to D. melanogaster and the An. gambiae
orthologs. These genes are present as single copy 1:1:1
orthologous trios. Ae. aegypti orthologs encode conserved
protein domains that identify them as RNAi components
(Figure 1). The major catalytic enzyme, Ae aegypti Ago2,
shares 42.7% amino acid (a.a.) identity with the An. gam-
biae ortholog and 33.2% identity with the D. melanogaster
ortholog (Additional File 1A). Similarly, Ae. aegypti Dcr2
shares 51.3% a.a. identity with An. gambiae Dcr2 and
31.1% with D. melanogaster (Additional File 1B).Ae aegypti
TSN shows more conservation across species, with 69.7%
and 63% a.a. identity, respectively (Additional File 1C).
These levels of similarity are common among proteins of
these species [20].
Effects of Ago2, Dcr2, or TSN dsRNA injection on TR339-
eGFP infection
To determine whether Ae. aegypti RNAi components are
required for defense against SINV TR339-eGFP, Dcr2,
Ago2, and TSN were silenced by injection of dsRNA 3 days
prior to an infectious bloodmeal. We predicted that
dsRNA injection would transiently silence expression of
these genes, because pre-existing RISC proteins should be
available to initiate the silencing process. Although both
TSN and Dcr2 transcripts showed evidence of transient
silencing in midguts following dsRNA injection, there was
no detectable reduction in Ago2 mRNA levels by qRT-PCR
(Figure 2A). However, there was a reduction in Ago2 116
Predicted protein domains of RNAi components used in this study compared to Drosophila orthologs Figure 1
Predicted protein domains of RNAi components used in this study compared to Drosophila orthologs. Ae aegypti 
orthologs: Ago2, [Vectorbase: SUPP_AEDES003395], supercontig 1.89; TSN, [Vectorbase: AAEL000293], supercontig 1.5; Dcr2, 
[Genbank: AY713296], supercontig 1.221. Drosophila orthologs: Ago2, [Genbank: NP_648775], chromosome 3L; Dcr2, [Gen-
bank: NP_523778], chromosome 2R; TSN [Genbank: NP_612021], chromosome 3L. "dsRNA", dsRNA binding; "DUF", domain 
of unknown function; "DEAD", helicase domain; "PAZ", small RNA binding domain; "PIWI", double-stranded RNA guided RNA 
cleavage; "RNase", RNA nuclease; "SNase", staphylococcal nuclease; "Tudor", domain of unknown function [51].
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kDa protein levels, compared to non-specific dsRNA-
injected controls, in unfed midguts just prior to an infec-
tious bloodmeal and at 2 dpi (Figure 2B). The silencing
was no longer evident by 3 dpi. On average, Ago2 protein
levels were reduced to 49% of controls (+/- 16%) imme-
diately prior to the virus meal and 22% of controls (+/-
17%) at 2 dpi. Previous reports showed that dsRNA effec-
tively silences most targeted genes in the midgut of several
different mosquito species for >7 days post-injection
[19,36,37]. In the current study, silencing of RNAi compo-
nents is more transient.
To determine if Ago2 dsRNA-injections altered virus repli-
cation, viral (+) and (-) RNA strands were detected by two-
TR339-eGFP virus infection transiently increased in mosquitoes receiving a Ago2, Dcr2, or TSN dsRNA injection Figure 2
TR339-eGFP virus infection transiently increased in mosquitoes receiving a Ago2, Dcr2, or TSN dsRNA injec-
tion. (A) qRT-PCR analysis. Percent reduction in cognate Dcr2, and TSN mRNA levels, relative to actin, in midguts following 
Ago2, Dcr2 or TSN dsRNA treatment. "ND", none detected. Asterisks indicate statistical significance (Mann Whitney U test P ≤ 
0.05). Error bars indicate standard error of three experimental replicates. (B) Immunoblot. Evidence of Ago2 protein silencing 
following dsRNA injection. "A" indicates Ago2 dsRNA-injected; "C" indicates βGAL injected controls. "0" days post-infection 
corresponds to female midguts harvested prior to virus meal. In each lane, equivalent amounts of protein extract from a pool 
of six midguts were separated by SDS-PAGE, blotted and probed with anti-Ago2 antibody. The loading control is a 19 kDa 
anti-Ago-2 cross-reacting band. Blot shown is from a single experiment and is representative of three independent replicates. 
(C) Two-step qRT- PCR showed that TR339 positive strand (+) RNA significantly increased in midguts of Ago2 dsRNA-injected 
mosquitoes over βGAL dsRNA controls at 1 dpi (P ≤ 0.05, Mann-Whitney U test). Pools of five midguts per group were used. 
Error bars depict standard error of three independent feedings. Viral (+) strand RNA copy numbers were calculated using the 
standard curve method. Asterisk indicates statistical significance, Mann-Whitney U test p ≤ 0.05. (D) TR339-eGFP viral titers of 
individuals at 4 dpi in Ago2, Dcr2, and TSN dsRNA-injected mosquitoes, with βGAL dsRNA controls. "**" indicates infection rate 
significantly higher than βGAL controls. "^^" above the graph indicates viral titers significantly higher than βGAL controls. Closed 
squares, Ago2 dsRNA; closed circles, βGAL dsRNA; closed diamonds, DCR2 dsRNA; closed triangles, TSN dsRNA; open 
squares, nsP3. Horizontal line indicates the median titer; no line indicates a median value of zero. "()" indicates (number of mos-
quitoes in each group per number positive). (E) TR339-eGFP viral titers at 7 dpi.
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step qRT-PCR of TR339-eGFP-infected mosquito midgut
pools. TR339-eGFP (+) strand RNAs showed a transient
increase over beta-galactosidase (βGAL)-injected controls
at 1 dpi (Figure 2C). The transient increase showed a high
variance, probably due to variability in the absolute
number of ingested viral particles per mosquito. Impor-
tantly, although viral copy number varied from experi-
ment to experiment, in each replicate, Ago2 dsRNA-treated
mosquito midguts showed higher viral copy number than
bGAL-treated. In contrast, no changes were observed in
the copy number of TR339-eGFP (-) strand RNA (data not
shown).
With the knowledge that RNAi component silencing
requires a functional RISC, we predicted that enhance-
ment of viral titers would be transient. Indeed, Ago2
silencing resulted in transient increases in TR339-eGFP
infection rates in whole mosquitoes (χ2 = 5.6, P = 0.02)
and increased median viral titers (Mann-Whitney U test, P
= 2e-15) (Figure 2D, Table 1). Viral eGFP fluorescence in
midguts of Ago2 -silenced mosquitoes was higher than
controls at 4 dpi (χ2 = 16.9, p = 4e-5); however, enhanced
viral infection and replication were no longer evident by
7 dpi (Figure 2E; Table 1). Together, these results indicate
the requirement for Ago2  in anti-viral defense during
TR339-eGFP infection.
A similar pattern of enhanced viral infection was observed
following Dcr2 dsRNA treatment. Transient Dcr2 silencing
resulted in temporary increases in TR339-eGFP infection
rates compared to controls (χ2 = 13.0, P = 0.0003) (Figure
2D), however increases in eGFP fluorescence were not sig-
nificant (Table 1). At 4 dpi, the Dcr2  dsRNA-injected
group also had significantly higher median titers than
βGAL controls (Figure 2D) (Mann Whitney U test, P =
0.0001), and, by 7 dpi, the effect was abrogated (Figure
2E). As was seen with Ago2, there is a clear requirement
for Dcr2 during anti-viral defense.
TSN silencing showed less striking enhancement of viral
infection than either Ago2 or Dcr2. At 4 dpi, median viral
titers of TSN-silenced mosquitoes were not significantly
different from controls (Figure 2D); however infection
rates were slightly higher (Mann Whitney U test, P = 0.03).
By 7 dpi, the infection pattern, detected by eGFP fluores-
cence showed significantly higher dissemination (χ2 = 5.2,
p = 0.02), even though clearing of midgut infection was
evident (Table 1). This fluorescence was primarily present
in hemolymph with very little in peripheral tissues. Con-
currently, viral titers were reduced to levels below those of
controls (Figure 2E). Importantly, detection of eGFP in
this system is indicative of viral protein production.
Therefore, the eGFP fluorescence in hemocytes coupled
with reduced viral titers indicates that only a small
Table 1: TR339-eGFP Infection Profiles following dsRNA Injection. Significantly enhanced viral eGFP fluorescence occurs at 4 dpi in 
midguts following Ago2 dsRNA treatment and in disseminated tissues at 7 dpi following TSN dsRNA treatment. 
Day 4 Day 7
dsRNA Midgut Dissemination Midgut Dissemination
βgal Light 28/47 (59.6%) 38/76 (50%)
Moderate 2/47 (4.3%) 5/76 (6.6%)
Heavy 3/47 (6.4%) 5/76 (6.6%)
Total 33/47 (70.2%) 10/33 (30%) 48/76 (63.2%) 12/48 (25%)
Ago2 Light 7/25 (28%) 20/53 (37.7%)
Moderate 6/25 (24%) 14/53 (26.4%)
Heavy 12/25 (48%) 5/53 (9.4%)
Total 25/25 (100%)** 12/25 (48%) 39/53 (73.5%) 5/39 (12.8%)
Dcr2 Light 9/20 (45%) 7/19 (36.8%)
Moderate 2/20 (10%) 2/19 (10.5%)
Heavy 0/20 (0%) 0/19 (0%)
Total 11/20 (55%) 5/11 (45.5%) 9/19 (47.3%) 3/9 (33.3%)
TSN Light 12/31 (38.7%) 10/37 (27%)
Moderate 4/31 (12.9%) 2/37 (5.4%)
Heavy 0/31 (0%) 3/37 (8.1%)
Total 16/31 (51.6%) 5/16 (31.3%) 15/37 (40.5%)^^ 15/15 (100%)**
nsP3 Light 1/32 (3.1%) 1/28 (3.6%)
Moderate 0/1 (0%) 0/28 (0%)
Heavy 0/32 (0%) 0/28 (0%)
Total 1/32 (3.1%)^^ 0/1 (0%) 1/28 (3.6%)^^ 0/1 (0%)
"()" indicates percentage eGFP detected in each group.
"**" indicates infection rate higher than βGAL controls. "^^" indicates infectious rate significantly lower than βGAL controls.
Light: 1–33% of the midgut infected; Moderate: 34–66%; Heavy: 67–100%; illustrations of infection patterns have been previously reported [33, 35].BMC Microbiology 2008, 8:47 http://www.biomedcentral.com/1471-2180/8/47
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amount of live virus escaped the midgut. Alternatively,
hemocytes became infected in the midgut and then
migrated to other tissues. Nevertheless, the virus was lim-
ited in its ability to replicate further. All of the results sug-
gest that the effects of silencing wane by 7 dpi. This could
be due to the decay of exogenously-administered dsRNA,
or transient stimulation of infection rates at 4 dpi might
be overcome by a stimulated anti-viral defense pathway
by 7 dpi.
SINV non-structural protein 3 (nsP3) participates in repli-
cation complex formation [38,39]. Injection of dsRNA
derived from TR339 nsP3 showed that this treatment
nearly ablated viral replication in 12 of 13 mosquitoes at
both 4 and 7 dpi (Figure 2D, 2E, Table 1). Midgut eGFP
fluorescence was significantly reduced in nsP3-targeted
mosquitoes (χ2 = 8.2, P = .00042) (Table 1). This evidence
demonstrates the ability of virus RNA-derived dsRNA to
trigger anti-viral RNAi in Ae aegypti.
Transient Ago2, Dcr2 or TSN silencing does not increase 
mortality during TR339-eGFP infection
Mutation of genes encoding RNAi pathway components
in D. melanogaster resulted in increased mortality of flies
infected with invertebrate viral pathogens [9,14]. In addi-
tion, there is evidence that some arboviruses cause pathol-
ogy in infected mosquito tissues [40-42]. To determine
whether RNAi components prevent mortality during SINV
infection, we examined survival curves of TR339-eGFP
infected  Ae. aegypti injected with Ago2, Dcr2 or  TSN
dsRNA. Results indicated that mortality was not increased
over  βGal  dsRNA-injected controls (Additional File 2).
The transient effects of the dsRNA injection or the weak
replication of TR339-eGFP may have been factors in the
lack of mortality. Therefore, the mortality study was
repeated with Dcr2  silenced mosquitoes infected with
MRE16-eGFP. Again, there was no significant enhance-
ment of mosquito mortality (Additional File 3). Neverthe-
less, to confirm these preliminary findings, a gene knock-
out system for mosquitoes would be required.
Evidence of RNAi pathway activity
The production of sequence-specific small RNAs is a hall-
mark of RNAi defense. RNAi activity was confirmed dur-
ing natural TR339-eGFP and MRE16-eGFP infections by
identifying viral small RNAs in adult female mosquitoes
(Figure 3). We used MRE16-eGFP whole genome capture
probes, as these two viruses share about 75% nucleotide
identity [43]. TR339-eGFP infected mosquitoes accumu-
lated far more small viral RNAs between 2 and 7 dpi than
MRE16-eGFP infected mosquitoes. Small viral RNAs from
MRE16-eGFP were barely detectable only at 2 dpi. These
data are interesting in light of the differences in replica-
tion kinetics of these two viruses (Figure 4). They could
indicate a correlation between replication efficiency in the
mosquito and susceptibility to the anti-viral RNAi
defense, or they could point to a viral suppressor of RNAi
in the MRE16-eGFP virus [4,10,44]. It is also apparent that
TR339-eGFP-derived (+) sense small RNAs are more
abundant than (-) sense small RNA in mosquito tissues.
This suggests that the (+) virus strand is targeted by RNAi
more efficiently than the (-) virus strand or that diced (+)
sense viral RNA is preferentially stabilized in the RISC and
used as the guide strand. It could also suggest that the pri-
mary viral dsRNA trigger is (+) sense viral RNA secondary
structure, rather than (+) and (-) dsRNA of the replicative
intermediate.
Mosquito and viral transcript analysis
The mosquito midgut is the initial site of arbovirus repli-
cation and thus is suspected to be the first site of anti-viral
defense. Blood-feeding alone results in reduced midgut
Dcr2 mRNA levels at 1 and 2 days post-feeding (Figure
4A) (Mann-Whitney U Test, P = 0.02 and P = 0.02, respec-
tively). Although fluctuations were also observed in Ago2,
Dcr2 and TSN mRNA levels at other timepoints, they were
not significantly different from controls.
TR339-eGFP and MRE16-eGFP replicate and amplify in
the midgut for 2 to 3 days prior to escape to other tissues
[33,35]. Mosquitoes were orally infected with either
MRE16-eGFP or TR339-eGFP, and RNAi component mid-
gut transcript levels were determined relative to un-
infected blood-fed controls (Figure 4B, 4D; Additional
File 4). The mosquito's overall transcript pattern differed
for each virus strain. During MRE16-eGFP infection, TSN
transcript levels, but not Ago2 or Dcr2, were significantly
enriched over controls at 1 and 3 dpi (Mann-Whitney U
Test, P = 0.05 and P = 0.04, respectively), and highly vari-
able at 2 dpi. In contrast, during TR339-eGFP infection,
Small viral RNAs are detected Figure 3
Small viral RNAs are detected. Small RNAs (18 to 25 
nts) were isolated from SINV-infected mosquitoes at 2 or 7 
days post-infection, size-selected by gel electrophoresis and 
hybridized to pools of strand-specific probes representing 
the complete viral genome indicated. Eluted products were 
separated on a 5% acrylamide gel and detected by autoradi-
ography. "Dpi", day, post-infection, "MRE", MRE16-eGFP-
infected, "TR339", TR339-eGFP-infected, "B", bloodfed con-
trol.
(-) MRE probe
dpi   7   2     7     2    7            7    2    7     2     7 
C MRE TR339 C MRE TR339
(+) MRE probe        BMC Microbiology 2008, 8:47 http://www.biomedcentral.com/1471-2180/8/47
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Non-infectious bloodmeal depletes Dcr2 transcripts; TSN transcript levels are enriched in mosquito midguts during SINV infec- tion Figure 4
Non-infectious bloodmeal depletes Dcr2 transcripts; TSN transcript levels are enriched in mosquito midguts 
during SINV infection. (A) Effects of bloodfeeding on Ago2, Dcr2, and TSN transcript levels. Relative midgut transcript levels 
from bloodfed mosquitoes were normalized to unfed controls. Transcript levels at 1.0 indicate no change over unfed control 
levels. (B) Effects of MRE16-eGFP infection on midgut transcript levels relative to un-infected bloodfed controls. (C) MRE16-
eGFP (-) strand RNA detected in midgut total RNA from panel (B). (D) Effects of TR339-eGFP infection on midgut transcript 
levels relative to un-infected bloodfed controls. (E) TR339-eGFP (-) strand RNA levels in midgut total RNA from panel (D). 
Mosquitoes were fed either a bloodmeal or the virus indicated. (A, B, D) Total RNA from pools of 5 midguts were used for 
qRT-PCR of Dcr2, Ago2, TSN and Act1 transcripts. Changes in relative transcript levels of each RNAi component were deter-
mined by using actin as an internal reference standard and normalizing each value to that of the control group indicated. Rela-
tive expression levels were determined using the comparative Ct method; transcript levels at 1.0 indicate no change over 
bloodfed control levels. Significant changes in expression levels are shown by asterisks (p ≤ 0.05, Mann-Whitney U test). Error 
bars depict standard error of three independent feedings. (C, E) Viral transcript copy numbers per nanogram midgut RNA 
were determined by two-step quantitative RT-PCR; these were calculated using the standard curve method. Error bars indi-
cate standard error of three independent virus infections.
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TSN transcript levels were not significantly enriched until
3 dpi, when a 5-fold enrichment was followed by a sharp
decrease at 4 dpi (Mann-Whitney U Test, P = 0.04 and P =
0.04, respectively).
Enhancement of Ae. aegypti TSN transcripts was previ-
ously reported in microarray analyses of SINV MRE16
infection [5]. The TSN transcript enrichment in Ae. aegypti
during SINV infection contrasts with reports of TSN
depletion in Drosophila during DCV infection [6]. DCV
has a single-stranded positive sense RNA genome, as does
SINV. However, DCV, a picorna-like virus, is an insect-
specific pathogen whereas SINV is an arbovirus, and by
definition, infects both mosquitoes and vertebrates and
establishes persistent, non-lethal infections in the insect
vector.
Detection of (-) strand RNA served as evidence of viral
replication in the samples used for RNAi component tran-
script analysis. Interestingly, viral replication markedly
differed between the two SINV strains. MRE16-eGFP (-)
RNA levels increased over the 7 day period, from an aver-
age of 276 copies per nanogram (ng) midgut RNA at 1 dpi
to 670 copies at 7 dpi (Figure 4C). In contrast, TR339-
eGFP (-) RNA was undetectable in 2 of 3 experimental
replicates at 1 dpi and increased to an average high of 33
copies at 2 dpi. Over the remainder of the 7 day time
course, (-) strand RNA levels remained low (Figure 4E).
The steady increase in (-) strand SINV RNA in mosquitoes
over the 7 day period differs from that observed in verte-
brate cell culture. In vertebrate cells, (-) strand RNA syn-
thesis ceases about 30 hr post-infection, due to the
cleavage of nsP1-4 products shifting replication towards
(+) strand synthesis [45]. The continued increase in (-)
strand RNA in midguts in contrast to that of vertebrate cell
culture is probably due to the progressive cell-to-cell
spread of virus through the tissue, whereas, in vitro cell
culture infection is initiated by bathing all cells in virus.
Importantly, despite clear differences in MRE16-eGFP and
TR339-eGFP growth characteristics, no statistically signif-
icant changes from controls were seen for Ago2 or Dcr2
mRNAs during SINV infection (Figure 4B, 4D). Further,
enrichment of TSN transcripts occurred at different times
following infection for each virus strain. Transcript enrich-
ment occurred early during MRE16-eGFP infection con-
comitant with viral replication, whereas, TSN enrichment
in TR339-eGFP infected midguts was delayed, possibly
because viral replication remained at low levels. These
results suggest that TSN may act as a sensor for the RNAi
pathway.
Ago2 protein profiles
The lack of statistically significant increases in Ago2 tran-
script levels during SINV infection led us to ask whether
protein levels fluctuated. Figure 5 shows Ago2 protein
profiles in MRE16-eGFP and TR339-eGFP infected mid-
guts compared to unfed and un-infected blood-fed con-
trols. Bloodfeeding alone reduces Ago2 protein levels
compared to midguts from unfed mosquitoes, and these
proteins re-accumulated over a time period concomitant
with the expected time course of bloodmeal digestion,
vitellogenesis, and a return to the unfed state.
Virus infection influenced Ago2 protein patterns in the
midgut. Depletion of Ago2 protein occurred during either
TR339-eGFP or MRE16-eGFP infection at 1 dpi; thereaf-
ter, Ago2 protein levels varied in a virus-dependent man-
ner, and were distinct from the profile seen in un-infected
controls. In MRE16-eGFP-infected midguts, Ago2 protein
remained depleted at 2 dpi and increased over un-infected
controls at 3 dpi. This enrichment corresponds to the con-
current, though statistically insignificant, increase in Ago2
transcripts (Figure 4B). In contrast, during TR339-eGFP
infection, Ago2 protein levels were enriched and evident
as multiple bands at 2 dpi, were roughly equivalent to
Ae aegypti Ago2 protein depletion and accumulation varied in  a virus-dependent manner Figure 5
Ae aegypti Ago2 protein depletion and accumulation 
varied in a virus-dependent manner. Protein was 
extracted from pools of ten midguts from unfed, bloodfed or 
virus/bloodfed adult female Ae aegypti at the time points indi-
cated. Equivalent protein amounts were separated by 4–15% 
gradient PAGE prior to blotting. Anti-Ae aegypti Ago2 anti-
body recognizes the carboxy-terminal peptide sequence 
YERMQIRTEIQDGHPMFFV. The loading control is a 19 kDa 
Ago2 cross-reacting band. "U", unfed female, "B", non-infec-
tious bloodfed female, "M", MRE16-eGFP-infected, "T", 
TR339-eGFP-infected. Blots are representative of two inde-
pendent experiments.
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bloodfed controls at 3 dpi, and reduced again at 4 dpi. By
7 dpi, protein profiles for all virus-infected midguts were
similar to those of bloodfed controls (data not shown).
When comparing natural fluctuations of Ago2 protein lev-
els in Figure 4 with those from dsRNA-injected mosqui-
toes in Figure 2, it is apparent that injection of non-
specific dsRNA results in depletion of Ago2 levels.
Summary
In summary, the low level of TR339-eGFP replication in
midguts, coupled with a lack of Ago2 protein depletion
and the detection of small viral RNAs, indicates that anti-
viral RNAi defense is active during infection with this
virus. The low steady state levels of (-) strand RNA
detected by qRT-PCR do not reveal fluctuations that could
occur due to RNA replication or degradation. Therefore,
further analysis is required to determine whether these
low levels are due to inefficient replication or an active
RNAi response. A much different pattern was observed
during MRE16-eGFP infection. MRE16-eGFP replicates to
significantly higher copy number than TR339-eGFP while
somehow preventing the accumulation of small viral
RNAs indicative of effective RNAi defense. The specifics of
this evasion or suppression mechanism are not under-
stood and warrant further study. Importantly, these
results underscore the different effects that can occur with
different arboviruses and indicate that specific effects on
the RNAi pathway need to be characterized separately for
each virus system.
Conclusion
The dissimilar growth kinetics of the two recombinant
SINV strains might be due to differences in ability to evade
RNAi defense. The parallel detection of virus replication,
viral small RNAs, and RNAi component transcripts and
proteins indicates that anti-viral defense occurs early in
infection. These data support the hypothesis that RNAi
anti-viral defense occurs in Ae. aegypti against SINV infec-
tion. The reduction of Ago2 protein levels soon after non-
infectious blood or SINV/blood meals suggests that
expression of new defense proteins may be a rate-limiting
step in anti-viral defense. Variations in Ago2, Dcr2, and
TSN transcripts and protein levels, as well as variation in
accumulation of viral small RNAs from infected mosqui-
toes, suggests that anti-viral defense activity differs in a
virus-dependent manner, potentially because some
viruses have the ability to avoid or suppress the RNAi
response. Our data also suggest that regulation of the
RNAi pathway in mosquitoes, as well as RNAi pathway/
arbovirus interactions, differ from those in non-vector
insects infected with pathogenic viruses. The first evidence
for this is that TSN, a transcriptional co-activator, tran-
scripts are enriched during arbovirus infection, whereas,
in Drosophila, this does not occur [6]. Moreover, mosqui-
toes with transiently silenced RNAi components, harbour-
ing higher SINV titers, did not exhibit increased mortality
as compared to controls, unlike Drosophila infected with
pathogenic insect viruses.
Future Directions
The differential effects of MRE16-eGFP and TR339-eGFP
on RNAi pathway activity indicate a need to investigate
the viral features that prevent or evoke RNAi pathway
activity. A deeper understanding of these virus-specific
effects will be important to defining the characteristics of
an efficient arbovirus and the limitations of RNAi anti-
viral defense in arbovirus vectors.
Methods
Virus infections and titrations
MRE16-eGFP and TR339-eGFP virus stocks were gener-
ated from SINV infectious cDNA clones with inserts of
enhanced GFP (eGFP) driven by the second sub-genomic
promoter, using standard methods [35,46,47]. MRE16-
eGFP was passed once in baby hamster kidney (BHK-21)
cells and twice in Aedes albopictus clone C6/36 cells. TR339
5'2J-eGFP was passed once in BHK-21 cells and three
times in C6/36 cells.
For mosquito feedings, all viruses were diluted as indi-
cated in de-fibrinated sheep blood and provided at 37°C
in a water jacketed artificial feeder with parafilm mem-
brane. An aliquot of each SINV stock was titered by viral
plaque assay on Vero cells and the other aliquots were
stored at -80°C and diluted prior to feeding. TR339-eGFP
blood-meals contained approximately 3.3 × 108 pfu/ml
and MRE16 meals contained 2.2 × 107 pfu/ml. Represent-
ative mosquitoes from each group were selected for dis-
section and eGFP detection with an Olympus epi-
fluorescence microscope to confirm midgut infection with
each batch of virus. Viral titers from individual mosqui-
toes were determined by plaque assays of filtered mos-
quito homogenates as previously described [29].
Mosquitoes and intrathoracic injection of dsRNA
Colonized Ae. aegypti Rexville D- Higgs' White Eye (HWE)
mosquitoes were reared at 28°C, 80% relative humidity,
with a photoperiod of 14:10 (L:D). Adults were provided
with a sugar source and water and held in the same condi-
tions during the extrinsic incubation period.
dsRNA was transcribed from templates generated from
cDNA clones following PCR amplification with 5' primer
extensions bearing a T7 RNA polymerase promoter (Addi-
tional File 4) and the protocol described with the Megas-
cript dsRNA kit (Ambion, Austin, TX). dsRNA was
purified with phenol/chloroform extraction and diluted
to a concentration of 1.0 μg/μl in phosphate-buffered
saline (PBS). Adult female Ae. aegypti (2–3 days post
emergence) were anesthetized with cold, held on ice andBMC Microbiology 2008, 8:47 http://www.biomedcentral.com/1471-2180/8/47
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intrathoracically injected with approximately 500 nano-
grams dsRNA. Three days later, mosquitoes were har-
vested for protein extraction or fed a blood-meal
containing 8 log pfu/ml TR339-eGFP.
Visualization of TR339-eGFP infection in Ae. aegypti 
mosquitoes
Evidence of virus infection and dissemination was
observed at 4 and 7 days post-infection (dpi) by dissecting
mosquitoes in PBS and observing eGFP fluorescence of
midguts and peripheral tissues by epi-fluorescence micro-
scopy (Olympus, Center Valley, PA).
Quantitative reverse transcriptase PCR (qRT-PCR)
Pools of 5 midguts from three independent feedings were
frozen at -80C prior to extraction of total RNA using Trizol
Reagent (Invitrogen, Carlsbad, CA). Genomic DNA was
removed using TurboDNase I (Ambion, Austin, TX) in a
100 μl reaction for 1 hour at 37°C and inactivated using
DNase I inactivation beads. Samples were stored as etha-
nol slurries at -80°C in multiple aliquots. Amplicons were
prepared in an Opticon 2 real-time PCR thermocycler
(BioRad, Hercules, CA) in triplicate using SYBR Green
One step qRT-PCR reagents (Invitrogen, Carlsbad, CA) in
20 μl reactions with 2.0 ng total RNA per well. Additional
File 4 shows the qPCR primers used. Cycling parameters
followed the manufacturer's recommendations and used
a 57°C extension temperature. Relative transcript levels
were determined using the comparative Ct analytical
method with an actin reference standard and the blood-
fed control as calibrator [48].
Viral RNA qRT-PCR
Two step amplification of (-) strand SINV RNA was per-
formed according to the methods of Richardson [49].
Briefly, 10 ng mosquito midgut total RNA were used for
reverse transcription reactions. For MRE16-eGFP and
TR339-eGFP, the forward primer (Additional File 4) was
used to transcribe (-) strand RNA. A 2 μl aliquot from the
reverse transcriptase reaction was used in quantitative
real-time PCR using ABI Powerscript (Applied Biosystems,
Foster City, CA). Viral copies were calculated using the
standard curve method [49].
Immunoblot analyses
All midguts were harvested into PBS with protease inhib-
itor cocktail (P2714, Sigma, St Louis, MO), flash frozen in
dry ice, stored at -80C, and processed simultaneously for
immunoblot analysis. Pools of 10 adult female midguts
were triturated in 1% sodium dodecyl sulfate, protease
inhibitor cocktail, 20 micrograms/ml phenylmethylsulfo-
nylfluoride (Sigma-Aldrich, St Louis, MO) diluted in PBS.
Equivalent amounts of protein extracts (10 υg) were sep-
arated using standard denaturing conditions on a 4 to
15% gradient gel and transferred to PVDF membrane
using a tank blotter (BioRad, Hercules, CA) and transfer
buffer containing 25 mM Tris, pH 8.3, 192 mM glycine.
Ago2 was detected using a 1:100 dilution of affinity puri-
fied rabbit anti- Ae. aegypti Ago2 antibody recognizing the
peptide sequence C-YERMQIRTEIQDGHPMFFV (QCB,
Hopkinton, MA). Antibody affinity purification followed
methods recommended by the antibody service company
(QCB, Hopkinton, MA). The corresponding genetic code
is present only once in the Ae. aegypti genome [50]. Multi-
ple banding patterns were observed; the predicted molec-
ular weight of Ago2 is 115 kilodaltons (kDa). The loading
control was a 19 kDa anti-Ago2 antibody cross-reacting
band that remained constant during all conditions. The
secondary antibody was goat anti-rabbit IgG conjugated
to horseradish peroxidase (Abcam, Cambridge, MA). Pro-
teins were detected using ECL Plus (GE Healthcare, Piscat-
away, NJ) detection reagents and ECL Hyperfilm (GE
Healthcare, Piscataway, NJ).
Small RNA detection
Mosquitoes were infected as described or fed blood alone
and held for 2 or 7 days prior to storage in Trizol reagent
(Invitrogen, Carlsbad, CA) at -80°C. Total RNA extraction
followed manufacturer's recommendations. Small RNAs
corresponding to 18–25 nucleotides were separated on a
7 M urea, 12% acrylamide gel, then excised and eluted.
These small RNAs were treated with calf intestinal alkaline
phosphatase to remove 5' phosphates and radiolabeled
using T4 polynucleotide kinase and gamma-32P ATP.
Radiolabeled RNAs were mixed with pooled biotinylated
viral probes, described below, in 10 mM Tris, pH 7.6 and
denatured for 1 min at 95°C. Reaction mixtures were
adjusted to 400 mM NaCl and incubated at 42°C for 4 hr
to allow hybridization. Streptavidin agarose beads were
added to the mixture, incubated at room temperature for
10 min to allow capture of the biotinylated probes, and
washed 4 times in 10 mM Tris, pH 7.6, 400 mM NaCl.
Radiolabeled small RNAs were eluted from the probes in
10 mM Tris, pH 7.6 at 95°C for 5 min. Eluted small RNAs
were concentrated by ethanol precipitation, separated on
a 5% acrylamide gel containing 7 M urea, and detected on
a Typhoon phosphorimager (GE Biosciences).
Biotinylated, strand-specific, viral RNA hybrid selection
probes were prepared by restriction endonuclease diges-
tion of the infectious MRE16-eGFP cDNA clone plasmid,
followed by PCR amplification of 3 to 5 kB portions of the
viral genome (Additional File 4). Each of these was used
as a template in transcription of biotinylated probes of (-
) or (+) strand polarity. Probes representing the (-) or (+)
viral strands were equally pooled to provide genome- or
anti-genome-wide coverage in the hybridization step.
TR339-eGFP was not used as a hybridization probe
because of inefficiencies in biotinylated RNA probe.BMC Microbiology 2008, 8:47 http://www.biomedcentral.com/1471-2180/8/47
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